M.D. Anderson Cancer Center: Liver Neoplasms trials

The registry lists 20 Liver Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 9Phase 2 9Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Development and Testing of a Patient-facing Educational Tool About Liver Cancer PreventionRecruitingNCT07010315
• Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or PancreasCompletedNCT01438476Phase 3Results posted
• Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line TherapyCompletedNCT01180959Phase 2Results posted
• Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver DiseaseCompletedNCT00543777Phase 1/2Results posted
• Folfox-B Study for Patients With Colorectal Liver MetastasesTerminatedNCT00508872Phase 2Results posted
• Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By SurgeryCompletedNCT00242502Phase 2Results posted
• TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment PlanningActive, not recruitingNCT05743842Not applicable
• A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line TherapyWithdrawnNCT05039736Phase 2
• Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid MalignanciesTerminatedNCT04785287Phase 1/2
• Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver CancerActive, not recruitingNCT03028311Phase 1
• Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid TumorsCompletedNCT02239900Phase 1
• Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant DiseaseWithdrawnNCT01864070Phase 1
• Hepatic Arterial Infusion (HAI) of AbraxaneCompletedNCT00732836Phase 1
• Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver LesionsCompletedNCT00527891
• Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and AvastinCompletedNCT00507585Phase 1
• Proton Therapy and Bevacizumab for Primary Liver TumorsTerminatedNCT00426829Phase 1
• Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyCompletedNCT00310115
• TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00077142Phase 1/2
• Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver CancerCompletedNCT00004136Phase 2
• Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney CancerWithdrawnNCT00003714Phase 2